Terpenoids of plant origin inhibit morphogenesis, adhesion, and biofilm formation by Candida albicans

Biofouling

Volumn 29, Issue 1, 2013, Pages 87-96

  Raut, Jayant S ^a   Shinde, Ravikumar B ^a   Chauhan, Nitin M ^a   Mohan Karuppayil, S ^a  

^a SWAMI RAMANAND TEERTH MARATHWADA UNIVERSITY   (India)

Author keywords

adhesion; biofilm; Candida albicans; drug resistance; morphogenesis; terpenoid

Indexed keywords

CANDIDA ALBICANS;

2,3 BIS (2 METHYLOXY 4 NITRO 5 SULFOPHENYL) 2H TETRAZOLIUM 5 CARBOXANILIDE; 2,3-BIS (2-METHYLOXY-4-NITRO-5-SULFOPHENYL)-2H-TETRAZOLIUM-5-CARBOXANILIDE; ANILIDE; ANTIFUNGAL AGENT; CRYSTAL VIOLET; ESSENTIAL OIL; TERPENE; TETRAZOLIUM;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL ADHESION; CHEMISTRY; DRUG EFFECT; FUNGUS HYPHAE; GROWTH, DEVELOPMENT AND AGING; MICROBIAL SENSITIVITY TEST; PATHOGENICITY; PHYSIOLOGY; VIRULENCE;

ANILIDES; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CELL ADHESION; GENTIAN VIOLET; HYPHAE; MICROBIAL SENSITIVITY TESTS; OILS, VOLATILE; TERPENES; TETRAZOLIUM SALTS; VIRULENCE;

EID: 84876436686     PISSN: 08927014     EISSN: 10292454     Source Type: Journal    
DOI: 10.1080/08927014.2012.749398     Document Type: Article

References (33)

1. Agarwal, V, Lal, P, and Pruthi, V. 2008. Prevention of Candida albicans biofilm by plant oils. Mycopathologia, 165: 13–19.
2. Bink, A, Pellens, K, Cammue, BPA, and Thevissen, K. 2011. Anti-biofilm strategies: how to eradicate Candida biofilms?. Open Mycol J, 5: 29–38.
3. Camacho, DP, Gasparetto, A, and Svidzinski, TIE. 2007. The effect of chlorhexidine and gentian violet on the adherence of Candida spp. to urinary catheters. Mycopathologia, 163: 261–266.
4. Campbell, BC, Chan, KL, and Kim, JH. 2012. Chemosensitization as a means to augment commercial antifungal agents. Front Microbiol, 3: 1–20.
5. Chandra, J, Kuhn, DM, Mukherjee, PK, Hoyer, LL, McCormic, T, and Gannoum, MA. 2001. Biofilm formation by fungal pathogen Candida albicans: development, architecture and drug resistance. J Bacteriol, 183: 5385–5394.
6. Chauhan, NM, Raut, JS, and Karuppayil, SM. 2011. A morphogenetic regulatory role for ethyl alcohol in Candida albicans. Mycoses, 54: e697–e703.
7. Clatworthy, AE, Pierson, E, and Hung, DT. 2007. Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol, 3: 541–548.
8. Cowan, MM. 1999. Plant products as antimicrobial agents. Clin Microbiol Rev, 12: 564–582.
9. Dalleau, S, Cateau, E, Berges, T, Berjeaud, JM, and Imbert, C. 2008. In vitro activity of terpenes against Candida biofilms. Int J Antimicrob Agents, 31: 572–576.
10. Davis-Hanna, A, Piispanen, AE, Stateva, LI, and Hogan, DA. 2008. Farnesol and dodecanol effects on the Candida albicans Ras 1-cAMP signaling pathway and the regulation of morphogenesis. Mol Biol, 67: 47–62.
11. Devkatte, A, Zore, GB, and Karuppayil, SM. 2005. Potential of plant oils as inhibitors of Candida albicans growth. FEMS Yeast Res, 5: 867–873.
12. Edris, AE. 2007. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review. Phytother Res, 21: 308–323.
13. Gershenzon, J, and Dudareva, N. 2007. The function of terpene natural products in the natural world. Nat Chem Biol, 3: 408–414.
14. Guo, N, Liu, J, Wu, X, Bi, X, Meng, R, Wang, X, Xiang, H, Deng, X, and Yu, L. 2009. Antifungal activity of thymol against clinical isolates of fluconazole-sensitive and -resistant Candida albicans. J Med Microbiol, 58: 1074–1079.
15. He, M, Du, M, Fan, M, and Bian, Z. 2007. In vitro activity of eugenol against Candida albicans biofilms. Mycopathologia, 163: 137–143.
16. Inouye, S, Takahashi, M, and Abe, S. 2009. Inhibitory activity of hydrosols, herbal teas and related essential oils against filament formation and the growth of Candida albicans. Jpn J Med Mycol, 50: 243–251.
17. Khan, MS, and Ahmad, I. 2012. Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms. J Antimicrob Chemother, 67: 618–621.
18. Khodavandi, A, Harmal, NS, Alizadehd, F, Scully, OJ, Sidike, SM, Othman, F, Sekawig, Z, Ng, KP, and Chong, PP. 2011. Comparison between allicin and fluconazole in Candida albicans biofilm inhibition and in suppression of HWP1 gene expression. Phytomed, 19: 56–63.
19. Kojic, EM, and Darouiche, RO. 2004. Candida infections on medical devices. Clin Microbiol Rev, 17: 255–267.
20. LaFleur, MD, Kumamoto, CA, and Lewis, K. 2006. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother, 50: 3839–3846.
21. Macros-Arias, C, Eraso, E, Madariaga, L, and Quindos, G. 2011. In vitro activities of natural products against oral Candida isolates from denture wearers. BMC Complement Altern Med, 11: 119
22. Mukherjee, PK, Chandra, J, Kuhn, DM, and Ghannoum, MA. 2003. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun, 71: 4333–4340.
23. Nickerson, KW, Atkin, AL, and Hornby, JM. 2006. Quorum sensing in dimorphic fungi: farnesol and beyond. Appl Environ Microbiol, 72: 3805–3813.
24. Pauli, A. 2006. Anticandidal low molecular compounds from higher plants with special reference to compounds from essential oils. Med Res Rev, 26: 223–268.
25. Pfaller, MA, and Diekema, DJ. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev, 20: 133–163.
26. Pfaller, MA, Messer, SA, and Coffmann, S. 1995. Comparison of visual and spectro-photometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870. J Clin Microbiol, 33: 1094–1097.
27. Pina-vaz, C, Rodrigues, AG, Pinto, E, Costa-de-Oliveira, S, Tavares, C, Salgueiro, L, Cavaleiro, C, Goncalves, MJ, and Martinez-de-Oliveira, J. 2004. Antifungal activity of Thymus oils and their major components. J Eur Acad Dermatol Vener, 18: 73–78.
28. Privett, BJ, Nutz, ST, and Schoenfisch, MH. 2010. Efficacy of surface-generated nitric oxide against Candida albicans adhesion and biofilm formation. Biofouling, 26: 973–983.
29. Rao, A, Zhang, Y, Muend, S, and Rao, R. 2010. Mechanism of antifungal activity of terpenoid phenols resembles calcium stress and inhibition of the TOR pathway. Antimicrob Agents Chemother, 54: 5062–5069.
30. Routh, MM, Raut, JS, and Karuppayil, SM. 2011. Dual properties of anticancer agents: an exploratory study on the in vitro anti-Candida properties of thirty drugs. Chemotherapy, 57: 372–380.
31. Shinde, RB, Raut, JS, and Karuppayil, SM. 2012. Biofilm formation by Candida albicans on various prosthetic materials and its fluconazole sensitivity: a kinetic study. Mycoscience, 53: 220–226.
32. Sudbery, P. 2011. Growth of Candida albicans hyphae. Nat Rev Microbiol, 9: 737–748.
33. Zore GB, Thakre AD, Jadhav S, Karuppayil SM. 2011. Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle. Phytomed. 18: 1181–1190.